Riskpilot← Back to searchSign inGet full accessNESENSIA AS
ASActiveOrg 991266380Lybekkveien 5C, 0772 OsloGeneral medical practice activities · NACE 8621Est. 20072 employees
Revenue 2025
NOK 7,9M
+16% vs 2024
EBITDA margin
36.1%
+29% vs 2024
Equity ratio
63.0%
Financial strength
Net profit 2025
NOK 1,9M
+21% vs 2024
| Revenue | NOK 7,9M | +16% |
| EBITDA | NOK 2,9M | +29% |
| Net profit | NOK 1,9M | +21% |
| Total assets | NOK 3,5M | +52% |
| Equity | NOK 2,2M | +23% |
| Employees | 2 | — |
Legal name
NESENSIA AS
Org number
991266380
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. juni 2007
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmennpraktiserende legevirksomhet, forskning og utvikling av helseprodukter, helserelaterte agenturer og investering i andre selskaper, eiendom og verdipapirer forøvrig.
Address
Lybekkveien 5C, 0772 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 736 | 1 529 | 6 158 | 6 840 | 7 915 |
| Staff expenses | −333 | −363 | −2 006 | −1 888 | −1 883 |
| EBITDA | −943 | 203 | 1 378 | 2 216 | 2 860 |
| Depreciation & amort. | −751 | −561 | −588 | −559 | −328 |
| EBIT | −1 694 | −359 | 790 | 1 657 | 2 533 |
| Net financials | 3 075 | 1 225 | 0 | −0 | −0 |
| Profit before tax | 1 381 | 866 | 790 | 1 657 | 2 532 |
| Tax | −0 | −0 | −0 | 71 | 613 |
| Net profit | 1 381 | 866 | 790 | 1 586 | 1 920 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 730 | 4 411 | 3 706 | 2 312 | 3 514 |
| Equity | 3 051 | 2 418 | 1 208 | 1 794 | 2 214 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 679 | 1 993 | 2 498 | 518 | 1 301 |
| Total debt | 2 679 | 1 993 | 2 498 | 518 | 1 301 |
EBITDA margin
36.1%
This company
15.8%
Market median
+128% vs market
20212025
Equity ratio
63.0%
This company
38.2%
Market median
+65% vs market
20212025
Return on equity
86.7%
This company
18.4%
Market median
+371% vs market
20212025
Net profit margin
24.3%
This company
8.1%
Market median
+200% vs market
20212025
Asset turnover
2.25×
This company
1.12×
Market median
+101% vs market
20212025
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2011 | |
| Board of Directors | 2011 | |
| Board of Directors | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NESENSIA AS 
RØA ØRE NESE HALS ASBoard members of NESENSIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Gisle Djupesland | Chairman | 0 companies |
| Nikolai Ilias Kyttaris Djupesland | Board of Directors | 0 companies |
| Helena Kyttari Djupesland | Board of Directors | 0 companies |